References
- Takamori M, Maruta T, Komai K. Lambert-Eaton myasthenic syndrome as an autoimmune calcium channelopathy. Neurosci Res 2000;36:183-91 https://doi.org/10.1016/S0168-0102(99)00135-2
- Lin JT, Lachmann E. Lambert-Eaton myasthenic syndrome: a case report and review of the literature. J Womens Health 2002;11:849-55 https://doi.org/10.1089/154099902762203696
- McEvoy KM. Diagnosis and treatment of Lambert- Eaton myasthenic syndrome. Neurol Clin 1994;12: 387-99
- O'Neill JH, Murray NM, Newsom-Davis J. The Lambert-Eaton myasthenic syndrome: a review of 50 cases. Brain 1988;111:577-96 https://doi.org/10.1093/brain/111.3.577
- Lambert EH, Eaton LM, Rooke ED. Defect of neuromuscular conduction associated with malignant neoplasms. Am J Physiol 1956;187:612-3
- Hwang YM, Sunwoo IN, Sun IJ. A case of Lambert- Eaton myasthenic syndrome. J Korean Neurol Assoc 1987;5:243-8
- Lee KH, Jeong MK, Hyun MS, Jeong JC, Lee HY, Ha JS, et al. Eaton-Lambert syndrome with small cell lung cancer. Yeungnam Univ J Med 1989;6:171-8
- Lee JH, Shin JH, Kim DS, Jung DS, Park KH, Lee MK, et al. A case of Lambert-Eaton myasthenic syndrome associated with atypical bronchopulmonary carcinoid tumor. J Korean Med Sci 2004;19:753-5 https://doi.org/10.3346/jkms.2004.19.5.753
- Moon JS, Sunwoo IN, Kim SM, Lee SA, Cho KH, Park KD, et al. Clinical analysis of 12 Korean Lambert- Eaton myasthenic syndrome (LEMS) patients. Yonsei Med J 1999;40:454-9
- Hong SJ, Chang CC. Inhibiton of acetylcholine release from mouse motor nerve by a P-type calcium channel blocker omega-agatoxin IVA. J Physiol 1995; 482:283-90
- Waterman SA. Role of N-, P- and Q- type voltagegated calcium channels in transmitter release from sympathetic neurones in the mouse isolated vas deferens. Br J Pharmacol 1997;120:393-8 https://doi.org/10.1038/sj.bjp.0700948
- Cherington M. Guanidine and germine in Eaton- Lambert syndrome. Neurology 1976;26:944-6 https://doi.org/10.1212/WNL.26.10.944
- Hawley RJ, Cohen MH, Saini N, Armbrustmacher VW. The carcinomatous neuromyopathy of oat cell lung cancer. Ann Neurol 1980;7:65-72 https://doi.org/10.1002/ana.410070112
- Newsom-Davis J, Murray NM. Plasma exchange and immunosuppressive drug treatment in the Lambert- Eaton myasthenic syndrome. Neurology 1984;34:480-5 https://doi.org/10.1212/WNL.34.4.480
- Zambelis T, Foutsitzi A, Giannakopoulou A, Poulopoulou K, Karandreas N. Lambert-Eaton myasthenic syndrome: clinical and electrophysiological findings in seven cases. Electromyogr Clin Neurophysiol 2004;44: 289-92
- Park SH, Choi SA, Yu TH, Kim GD, Kim SK, Chang J, et al. A case of Lambert-Eaton myasthenic syndrome improved after surgical resection for diagnosis of small cell carcinoma of the lung. Tuberc Respir Dis 1998;45:596-603
- Jenkyn LR, Brooks PL, Forcier RJ, Maurer LH, Ochoa J. Remission of the Lambert-Eaton syndrome and small cell anaplastic carcinoma of the lung induced by chemotherapy and radiotherapy. Cancer 1980;46: 1123-7 https://doi.org/10.1002/1097-0142(19800901)46:5<1123::AID-CNCR2820460508>3.0.CO;2-L
- Chalk CH, Murray NM, Newsom-Davis J, O'Neill JH, Spiro SG. Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small cell lung carcinoma. Neurology 1990;40:1552-6 https://doi.org/10.1212/WNL.40.10.1552
- McEvoy KM, Windebank AJ, Daube JR, Low PA. 3,4- Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome. N Engl J Med 1989;321:1567- 71 https://doi.org/10.1056/NEJM198912073212303
- O SJ, Kim KW. Guanidine hydrocholride in the Eaton-Lambert syndrome: electorophysiologic improvement. Neurology 1973;23:1084-90 https://doi.org/10.1212/WNL.23.10.1084